MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It utilizes its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy and dilated cardiomyopathy. The company was founded in 2012 and is headquartered in Brisbane, California.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of MyoKardia Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. MyoKardia Inc market cap is $11.99B.
What is the 52-week high for MyoKardia Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. MyoKardia Inc 52 week high is $225.00 as of September 09, 2025.
What is the 52-week low for MyoKardia Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MyoKardia Inc 52 week low is $42.65 as of September 09, 2025.
What was MyoKardia Inc stock price yesterday?
MyoKardia Inc stock price yesterday was $224.91.
What is the PE ratio of MyoKardia Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. MyoKardia Inc’s P/E ratio is -39.87.
What is the Price-to-Book ratio of MyoKardia Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. MyoKardia Inc P/B ratio is 14.1893.
What is the 50-day moving average of MyoKardia Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. MyoKardia Inc 50-day moving average is $189.15.